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Innate immune recognition controls adaptive
immune responses through multiple mechanisms.
The MyD88 signaling adaptor operates in many cell
types downstream of Toll-like receptors (TLRs) and
interleukin-1 (IL-1) receptor family members. Cell-
type-specific functions of MyD88 signaling remain
poorly characterized. Here, we have shown that the
T cell-specific ablation of MyD88 in mice impairs
not only T helper 17 (Th17) cell responses, but also
Th1 cell responses. MyD88 relayed signals of TLR-
induced IL-1, which became dispensable for Th1
cell responses in the absence of T regulatory (Treg)
cells. Treg cell-specific ablation of MyD88 had no
effect, suggesting that IL-1 acts on naive CD4+
T cells instead of Treg cells themselves. Together,
these findings demonstrate that IL-1 renders naive
CD4+ T cells refractory to Treg cell-mediated sup-
pression in order to allow their differentiation into
Th1 cells. In addition, IL-1 was also important for
the generation of functional CD4+ memory T cells.
INTRODUCTION
The innate instruction of adaptive immunity is controlled on
multiple levels. The activation of pattern recognition receptors
(PRRs) such as Toll-like receptors (TLRs) in dendritic cells
(DCs) leads to the upregulation of costimulatory molecules and
secretion of proinflammatory cytokines. This activation program
provides a critical layer in the discrimination between self and
non-self and is essential for the activation of T cell responses
(Iwasaki and Medzhitov, 2010; Schenten and Medzhitov,78 Immunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc.2011). Despite the progress in the general understanding of the
rules that govern the interaction between DCs and cognate
CD4+ T cells following TLR activation, the specific roles of indi-
vidual TLR-induced cytokines and T cell-specific TLR signals in
shaping CD4+ T cell responses remain incompletely understood.
CD4+ T cells express several TLRs, although the precise
patterns of TLR expression in particular CD4+ T cell subsets
are still subject to debate (Cairns et al., 2006; Caramalho et al.,
2003; Fukata et al., 2008; Gelman et al., 2004; Gonza´lez-Navajas
et al., 2010; Kabelitz, 2007). Multiple studies have demonstrated
various effects of TLR stimulation in T cells. For example, the
stimulation of CD4+ T cells with TLR9 agonists causes enhanced
proliferation, survival, and secretion of interleukin-2 (IL-2)
(Gelman et al., 2004). Similarly, T cell-specific TLR2 activation
can enhance the generation of Th17 cell responses (Reynolds
et al., 2010). Some TLRs also appear to influence naturally-
occurring CD4+ CD25+ Treg cells directly by dampening their
suppressive capabilities, in part by lowering the expression of
FoxP3, the lineage-defining transcription factors of these cells
(LaRosa et al., 2007; Liu et al., 2006; Sutmuller et al., 2006).
Thus, TLRs seem to modulate both CD4+ effector T cell and
Treg cell responses simultaneously in order to promote the gen-
eration of CD4+ T cell responses.
Members of the IL-1 family of cytokines are known to control
several aspects of T cell responses directly (Dinarello, 2009;
Sims and Smith, 2010). In recent years, IL-1 has received
much attention because of its involvement in the differentiation
of Th17 cells. These cells express the IL-1 receptor (IL-1R) and
several studies have suggested that IL-1 enhances the differen-
tiation of naive CD4+ T cells into Th17 cells in vitro (Acosta-
Rodriguez et al., 2007; Chung et al., 2009; Kryczek et al., 2007;
Wilson et al., 2007). IL-1 signaling in CD4+ T cells is also impor-
tant for the induction of Th17 cells in vivo, which is illustrated by
the observation that CD4+ T cells deficient in IL-1 signaling fail
to induce the Th17 cell-dependent diseases experimental
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MyD88 Signaling in CD4+ T Cells Blocks Treg Cellsautoimmune encephalomyelitis (EAE) and colitis (Chung et al.,
2009; Fukata et al., 2008; Sutton et al., 2006; Tomita et al.,
2008). In addition to its role in Th17 cell biology, however, it
has been suggested that IL-1 plays an important role in the gen-
eration of both primary as well as secondary Th1 cell responses
(Ben-Sasson et al., 2009; Sims and Smith, 2010). Some studies
detect the IL-1R on naive and Th1 cells, whereas others find no
evidence for this (Chung et al., 2009; Guo et al., 2009; Taylor-
Robinson and Phillips, 1994). Nonetheless, it seems clear that
IL-1 signaling contributes to the generation of Th1 cell re-
sponses. For example, it has been suggested to promote the
upregulation of the IL-2 receptor a chain (CD25), prevent
apoptosis, and enhance Th1 cell expansion (Ben-Sasson et al.,
2009; O’Neill, 2008). Moreover, bone marrow chimeras
harboring IL-1R-deficient T cells have reduced numbers of Th1
cells during the course of EAE (Ben-Sasson et al., 2009; Chung
et al., 2009). Therefore, IL-1 plays a role in the generation of
both Th1 and Th17 cell responses. In contrast, the IL-1-related
cytokine IL-18 seems to be more exclusively linked to the gener-
ation of Th1 cell responses because Th1 cells can express high
amounts of the IL-18R in a T-bet-dependent fashion. In this
regard, the function of IL-18 in Th1 cells might parallel that of
IL-1 and IL-33 in Th17 and Th2 cells, respectively, namely to rein-
force or stabilize CD4+ T cell lineage commitments (Guo et al.,
2009). Thus, members of the IL-1 family appear to be involved
in both the activation of CD4+ T cells and maintaining the subse-
quent lineage commitment decision. In addition to its effects on
the development of specific CD4+ T effector subsets, IL-1
signaling also appears to regulate the interaction between
effector T cells and Treg cells. Treg cells express the IL-1R,
even though the roles of IL-1 on Treg cell function are not clearly
understood (Chaudhry et al., 2009; Mercer et al., 2010). None-
theless, IL-1 might influence the function of Treg cells directly
by blocking the suppressive function of Treg cells (O’Sullivan
et al., 2006). Treg cells are also thought to deprive CD4+ effector
T cells of IL-1 (Chaudhry et al., 2009). Moreover, IL-1 has been
implicated enabling the conversion of induced Treg cells into
Th17 cells (Chung et al., 2009).
Despite this progress in the understanding of TLR and IL-1
biology, the T cell-specific function of these signals are still
incompletely understood, in part due to the pleiotropic nature
of these triggers. In this study, we sought to investigate the
T cell-specific roles of TLRs, IL-1, and IL-18 on the generation
of CD4+ T cell responses in vivo. We report on the generation
and analysis of mice carrying a T cell-specific ablation of
Myd88, the essential signaling adaptor of most TLRs and recep-
tors of the IL-1 family. Our study identifies a function for IL-1 in
rendering CD4+ T cells refractory to Treg cell-mediated suppres-
sion. In addition, we show that IL-1 is also necessary to generate
functional Th1 memory cells.
RESULTS
T Cell-Specific MyD88 Signaling Is Required for the
Induction of Both Th1 and Th17 Cell Responses
In order to investigate the T cell-specific function of signals
induced by TLRs and IL-1 family members, we generated
mice carrying a T cell-specific ablation of MyD88. We flanked
exons 3–5 of the Myd88 gene with loxP sites to allow itsdeletion by Cre-mediated recombination. These exons encode
the essential Toll-IL-1 receptor (TIR) domain of MyD88. More-
over, splicing from exon 2 to exon 6 resulted in a frameshift
mutation. The targeting strategy and generation of the mice
is outlined in Figures S1A–S1C available online. We inter-
crossed the resulting Myd88FL/+ mice with Cd4-cre mice in
order to obtain Myd88FL/FL Cd4-cre mice, which ablated
Myd88 in all T cells (Figure S1D).
We immunized Myd88FL/FL Cd4-cre and control mice with
ovalbumin (OVA) in the presence of lipopolysaccharide (LPS) in
incomplete Freund’s adjuvant (IFA) as a carrier and measured
the ensuing CD4+ T cell response. To this end, we isolated
CD4+ T cells from the draining lymph nodes 7 days after
immunization, at which point the majority of cells displayed a
phenotype of CXCR5+ PD-1+ T follicular helper (Tfh) cells (Fig-
ure S2A), and restimulated the cells with OVA in the presence
of irradiated splenocytes as antigen presenting cells (APCs)
in vitro. Wild-type (WT) CD4+ T cells proliferated robustly and
secreted both interferon-g (IFN-g) and IL-17, whereas MyD88-
deficient CD4+ T cells were significantly impaired in their ability
to proliferate and secrete both IFN-g and IL-17 (Figures 1A and
1B, Figures S4A and S4B). Because dying cells, such as irradi-
ated splenocytes, might have been a source of IL-1 in the
T cell cultures and thus might have affected the experimental
outcome during the in vitro phase of the assay, we controlled
for the presence of IL-1 in the cultures. We could detect IL-1a
and IL-1b in cultured macrophages after stimulation with LPS
and ATP, but failed to do so in the T cell assays after restimula-
tion with OVA, even in the presence of a 4-fold higher number of
irradiated splenocytes (Figure S2B). Indeed, CD4+ T cells from
Myd88FL/FL Cd4-cre mice also failed to expand and secrete
IFN-g after restimulation in the presence of irradiated APCs
from Caspase-1-deficient mice, which are impaired in their abil-
ity to secrete IL-1 (Figures S2C and S2D). These results suggest
that IL-1 released by dying APCs after in vitro stimulation with
antigen is not responsible for the defects observed in MyD88-
deficient CD4+ T cells. The impairment of the CD4+ T cell
response in Myd88FL/FL Cd4-cre mice was therefore due to
defective IL-1 signaling in vivo.
In order to assess whether the activation of other TLRs
results in a similar defect of the CD4+ T cell response in
Myd88FL/FL Cd4-cre mice, we also immunized mice with
OVA plus either polyIC or CpG DNA in IFA as a carrier. The
CD4+ T cell response of Myd88FL/FL Cd4-cre mice was also
defective with these additional stimuli (Figures S2E and S2F).
We obtained similar results following immunization with OVA
in the more complex complete Freund’s adjuvant (CFA) (Fig-
ure S2G). Next, we asked whether the impairment of the
CD4+ T cell response was caused by a defect in the generation
or function of the cells. We therefore immunized the mice with
2W peptide in the presence of LPS and IFA, because this sys-
tem allows for the tracking of the antigen-specific CD4+ T cells
with 2W:I-Ab tetramers (Moon et al., 2007). Upon immunization
with 2W peptide, the Th1 cell response in Myd88FL/FL Cd4-cre
mice was also impaired, suggesting that the choice of antigen
does not influence the outcome of the T cell response as
measured by restimulation (Figure 1C). At the peak of the
response, activated CD44+ CD4+ T cells specific for the 2W
peptide in the draining lymph nodes of Myd88FL/FL Cd4-creImmunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc. 79
Figure 1. Impaired CD4+ T Cells Response in Myd88FL/FL Cd4-cre Mice
(A and B) Proliferation of CD4+ T cells from Myd88FL/FL Cd4-cre mice and WT controls. CD4+ T cells were isolated from the draining lymph nodes 7 days after
immunization in the feet with OVA + LPS in IFA and restimulated with OVA in the presence of irradiated splenocytes. Proliferation (A) and cytokine secretion (B)
were measured 3 days later by 3H-thymidine incorporation and ELISA, respectively. Shown is the mean ± SD.
(C) Th1 cell response in Myd88FL/FL Cd4-cre mice and WT controls after immunization with 2W peptide + LPS in IFA and restimulation with 2W peptide. Shown
is the mean ± SD.
(D) Frequency of 2W:I-Ab+ CD4+ T cells in Myd88FL/FL Cd4-cre and WT control mice T cells 7 days after footpad immunization with 2W peptide + LPS in IFA.
(E) Cytokine production of 2W:I-Ab+ CD4+ T cells in Myd88FL/FL Cd4-cre and WT control mice after restimulation with an aCD3e antibody.
(F) Absolute numbers of all cells, CD4+ T cells, and 2W:I-Ab+ CD4+ T cells in the draining lymph nodes ofMyd88FL/FLCd4-cre andWT controls immunized with 2W
peptide + LPS in IFA 7 days earlier. For all experiments, a representative out of at least three independent experiments is shown. See also Figure S1 and S2.
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MyD88 Signaling in CD4+ T Cells Blocks Treg Cellsmice were as frequent as in WT controls (Figure 1D). While the
cellular composition of the lymph nodes did not change after
immunization (data not shown), the number of cells in the drain-80 Immunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc.ing lymph nodes of Myd88FL/FL Cd4-cre mice was reduced
compared to that of control mice, leading to a reduction
in the absolute number of 2W:I-Ab-positive CD4+ T cells in
Figure 2. Proliferation, Viability, and Differentation of 2W:IA(b)+ CD4+ T Cells from Myd88FL/FL Cd4-cre and WT Control Mice
(A) Proliferation of antigen-specific 2W:I-A(b)+ CD4+ T cells in the draining lymph nodes of Myd88FL/FL Cd4-cre and WT control mice between day 4–7 after
immunization with 2W peptide + LPS in IFA as measured by incorporation of BrdU. Left panel shows a representative experiment. Right panel shows statistical
representation of the combined data of three independent experiments, normalized to the level of BrdU incorporation of 2W:I-A(b)+ CD4+ T cells of Myd88FL/FL
Cd4-cre mice. Each dot represents one mouse.
(B) Frequency of apoptotic antigen-specific 2W:I-A(b)+ CD4+ T cells in the draining lymph nodes of Myd88FL/FL Cd4-cre and WT control mice on day 7 after
immunization with 2W peptide + LPS in IFA, measured by staining for active caspase-3. Shown is the mean ± SD of the combined data of two independent
experiments using a total of four mice per genoptype.
(C) T-bet expression by qPCR in immunized CD4+ T cells in the draining lymph nodes ofMyd88FL/FL Cd4-cre and WT control mice. A representative experiment
out of two independent experiments, each using the pooled samples from 5–10 mice per genotype, is shown. Error bars reflect the SD.
Immunity
MyD88 Signaling in CD4+ T Cells Blocks Treg CellsMyd88FL/FL Cd4-cre mice, which might have been caused by a
failure of the antigen-specific T cells to secrete inflammatory
cytokines (Figure 1E).
Consistent with normal frequency of antigen-specific CD4+
T cells in Myd88FL/FL Cd4-cre mice, these cells incorporated
BrdU into their DNA as efficiently as WT controls, implying that
the clonal expansion of antigen-specific CD4+ T cells is not
impaired in Myd88FL/FL Cd4-cre mice (Figure 2A). CD4+ T cells
from these mice also did not display an increased tendency to
undergo apoptosis (Figure 2B). However, antigen-specific 2W+
CD4+ T cells of Myd88FL/FL Cd4-cre mice expressed loweramounts of T-bet, the lineage-defining transcription factor of
Th1 cells, when compared to WT control cells (Figure 2C).
Together, our findings therefore demonstrate that T cell-specific
MyD88 signaling is required for the generation of functionally
competent Th1 cells, even though the initial expansion of the
antigen-specific CD4+ T cells is not compromised.
Impaired CD4+ T Cell Response in Myd88FL/FL Cd4-cre
Mice Is Caused by Defective IL-1 Signaling
MyD88 relays signals from most TLRs and also from members
of the IL-1 family. In order to distinguish between these twoImmunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc. 81
Figure 3. Impaired CD4+ T Cells Response
in Myd88FL/FL Cd4-cre Mice Is Caused by
Defective IL-1 Signaling
(A and B) Expression of the receptors for IL-1 (A)
and IL-18 (B) in CD4+ T cells in the draining lymph
nodes of immunized Myd88FL/FL Cd4-cre and WT
control mice as measured by qPCR. The expres-
sion levels were normalized to that of naive CD4+
T cells. A representative experiment out of three
independent experiments, each using the pooled
samples from 5–10 mice per genotype, is shown.
Shown is the mean ± SD.
(C–F) CD4+ T cell response of Rag2-deficient mice
reconstituted with a 3:1 mix of bone marrow from
TCRb-deficient mice and Il1r/ mice, Il18r/
mice, Tlr2/ and Tlr4/ compound mutant mice
or WT controls, respectively. Isolated CD4+ T cells
were restimulated with OVA after the immunzation
of themicewithOVA+ LPS in IFA. The proliferation
was measured 3 days later by 3H-thymidine
incorporation (C and E) and cytokine secretion
was measured by ELISA (D and F). A representa-
tive experiment out of three independent experi-
ments is shown. Error bars reflect SD. See also
Figure S3.
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receptors on antigen-specific T cells 7 days after immuniza-
tion with 2W peptide and LPS in IFA. We detected an upre-
gulation of the IL-1R in antigen-specific CD4+ T cells from
both Myd88FL/FL Cd4-cre mice and WT controls compared
to naive CD4+ T cells. In contrast, the IL-18R was downregu-
lated in all CD4+ T cells from both Myd88FL/FL Cd4-cre mice
and WT controls compared to naive CD4+ T cells (Figures 3A
and 3B).
The regulation of the IL-1R implicated IL-1 signaling as an
important event in the generation of the CD4+ T cell response,
but did not rule out an involvement of TLR or IL-18R signaling.
We therefore generated mixed bone marrow chimeras, in which
the T cell compartment consisted of T cells derived from TLR2-
and TLR4-deficient compound mutant mice, IL-1R-deficient
mice, IL-18R-deficient mice, or WT mice. Chimeric mice
harboring aWT, a TLR2- and TLR4-deficient, or IL-18R-deficient
T cell compartment mounted a robust CD4+ T cell response
following immunization with OVA + LPS in IFA. In contrast, pro-82 Immunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc.liferation and cytokine secretion of
IL-1R-deficient CD4+ T cells was signifi-
cantly impaired. (Figures 3C–3D; Fig-
ure S3A and S3B).
We obtained similar results for bone
marrow chimeras that carried either a
TLR9- or IL-1R-deficient T cell compart-
ment, which we had immunized with
OVA and CpG DNA in IFA. We noticed
in some, but not all, experiments a
moderate contribution of TLR9 signaling
to the response, consistent with the
suggested role of T cell-intrinsic TLR9
signaling in the generation of CD4+
T cell responses (Gelman et al., 2004).However, IL-1 signaling was also required under these condi-
tions (Figures S3C–S3F). Thus, our results collectively demon-
strate that the defective CD4+ T cell response in Myd88FL/FL
Cd4-cremice is caused by the inability of the T cells to recognize
IL-1 signals, whereas TLR-driven signals play a minor role.
IL-1 Signaling Is Required to Render CD4+ T Cells
Refractory to Treg Cell-Mediated Suppression
We had previously shown that transient depletion of regulatory T
(Treg) cells in complete MyD88-deficient mice is able to restore
the Th1 cell response (Pasare and Medzhitov, 2004). However,
neither the molecular signals nor the cell type responsible for
this phenotype were known. In light of our current results, we
asked whether IL-1 signaling regulates the interplay between
the naive CD4+ T cell population and the Treg cell population.
In order to analyze the CD4+ T cell response in the absence of
Treg cells, we depleted CD25+ Treg cells from Myd88FL/FL
Cd4-cre and control mice with a monoclonal aCD25 antibody
three days prior to immunization with OVA and LPS in IFA. We
Figure 4. Induction of a Th1 Cell Response Requires T Cell-Specific MyD88 Signaling in Naive CD4+ T Cells in Order to Overcome Treg
Cell-Mediated Suppression
(A and B) Restoration of the Th1 cell response after transient depletion of CD25+ Treg cells inMyd88FL/FL Cd4-cre following the transient depletion of Treg cells
with an aCD25 antibody and subsequent immunization with OVA + LPS in IFA 3 days later. Isolated CD4+ T cells were restimulated with OVA 7 days after
immunization. Proliferation (A) and cytokine secretion (B) of the CD4+ T cells were measured 3 days later. A representative experiment out of at least three
independent experiments is shown. Shown is the mean ± SD.
(C and D) CD4+ T cell response inMyd88FL/FL Foxp3-cremice andWT controls. Themice were immunized and the proliferation (C) and cytokine secretion (D) was
measured as described before. A representative experiment out of three independent experiments is shown. All error bars reflect SD. See also Figure S4.
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zation by flow cytometry of blood leukocytes (data not shown).
Treg cell depletion was unable to restore the Th17 cell response
in Myd88FL/FL Cd4-cre mice, consistent with a requirement for
IL-1 signaling in the differentiation of these cells. However, in
the absence of Treg cells, proliferation and secretion of IFN-g
by restimulated CD4+ T cells was restored inMyd88FL/FLCd4-cre
(Figures 4A and 4B, Figures S4A and S4B). We obtained similar
results after immunization of Treg cell-depleted Myd88FL/FL
Cd4-cre mice and WT controls with OVA + CpG DNA (Figures
S4C and S4F).
While these results suggested that IL-1 signaling in CD4+
T cells might function to overcome Treg cell-mediated suppres-
sion, they did not distinguish between the effects of IL-1 on the
various CD4+ T cell populations. Because IL-1 might be acting
on Treg cells directly (Mercer et al., 2010; O’Sullivan et al.,
2006), we generated mice in whichMyd88 is specifically ablated
in FoxP3+ Treg cells by expression of the Foxp3-cre allele
(Myd88FL/FL Foxp3-cre mice). Immunization of Myd88FL/FL
Foxp3-cre mice with OVA and LPS in IFA revealed that these
micemounted CD4+ T cell responses that were indistinguishable
from WT controls (Figures 4C and 4D). Thus, these resultsindicate that IL-1 does not act on Treg cells, but instead is
required in naive or effector CD4+ T cells in order to render these
cells refractory to Treg cell-mediated suppression.
IL-1 Signaling Does Not Cause an Increased Frequency
of Induced Treg Cells
The results so far implied a requirement for IL-1 in naive or
effector CD4+ T cells to overcome suppression by ‘‘naturally-
occurring’’ Treg cells (nTreg cells). However, TLR-induced
cytokines such as IL-6 can affect the balance between the
frequencies of Th17 cells and transforming growth factor-b
(TGF-b)-induced (iTreg) cells, and this mechanism can result in
an increased frequency of iTreg cells under conditions where
the development of Th17 cells is genetically compromised. A
similar function has recently been suggested for IL-1 (Chung
et al., 2009). The absence of a Th17 cell response inMyd88FL/FL
Cd4-cre mice might therefore lead to an increased frequency of
iTreg cells, which could provide an alternative explanation for the
impaired Th1 cell response in Myd88FL/FL Cd4-cre mice. Thus,
we investigated whether the frequency of iTreg cells was
increased in Myd88FL/FL Cd4-cre mice. We did not observe an
increased frequency of FoxP3+ Treg cells in unimmunizedImmunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc. 83
Figure 5. Frequency of Treg Cells Myd88FL/FL Cd4-cre Mice
(A) Frequency of FoxP3+ Treg cells in unimmunized WT and Myd88FL/FL Cd4-cre mice.
(B) Frequency of FoxP3+ Treg cells after immunization with OVA + LPS in IFA and subsequent restimulation of isolated CD4+ T cells with OVA.
(C) Frequency of FoxP3+ Treg cells in WT and Myd88FL/FL Cd4-cre mice in the draining lymph nodes 7 days after immunization with OVA + LPS in IFA.
(D and E) Frequency of antigen-specific FoxP3+ 2W:I-A(b)+ Treg cells in the draining lymph nodes 7 days after immunization with 2W peptide + LPS in IFA, shown
as percentage of all CD4+ T cells (D) or percentage of all 2W:I-A(b)+ CD4+ T cells (E). For all experiments (A–E), a representative experiment out of three
independent experiments is shown.
(F) Absolute numbers of FoxP3+ 2W:I-A(b)+ Treg cells in the draining lymph nodes 7 days after immunization with 2W peptide + LPS in IFA.
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MyD88 Signaling in CD4+ T Cells Blocks Treg CellsMyd88FL/FL Cd4-cremice (Figure 5A). Similarly, the frequency of
Treg cells was also not altered inMyd88FL/FL Cd4-cremice after
immunization with OVA and LPS in IFA and subsequent restimu-
lation in vitro (Figure 5B). In order to measure the frequency of
Treg cells more directly, we also analyzed their presence in the
draining lymph nodes of immunized mice. Although we noticed
a modest tendency of a higher frequency of Treg cells in the
draining lymph nodes of some immunized Myd88FL/FL Cd4-cre
mice, we did not detect consistent differences between these
mice and WT controls (Figure 5C). Because it remained possible
that the lack of IL-1 signaling in the T cells ofMyd88FL/FLCd4-cre
mice alters the frequency of antigen-specific Treg cells, we
immunized Myd88FL/FL Cd4-cre mice and WT controls with 2W
peptide and LPS in IFA and measured the frequency of 2W:I-
Ab+ FoxP3+ Treg cells in the draining lymph nodes 7 days later.
Neither the frequency of these cells as a percentage of total
CD4+ T cells, nor as percentage of antigen-specific 2W:I-Ab+
CD4+ T cells was changed in Myd88FL/FL Cd4-cre mice
compared to WT mice (Figures 5D and 5E). Consistent with of
the overall reduced size of the lymph nodes of immunized
Myd88FL/FL Cd4-cre mice, we also observed a trend toward
lower absolute numbers of 2W:I-Ab+ FoxP3+ Treg cells in
Myd88FL/FL Cd4-cre mice compared to WT mice (Figures 1E
and 5F). Thus, we conclude that T cell-intrinsic MyD88 signaling
does not affect the frequency of induced Treg cells, at least not
under the conditions used in this study.84 Immunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc.Impaired Memory CD4+ T Cell Response inMyd88FL/FL
Cd4-cre Mice
The absence of Treg cells prior to the immunization enables a
Th1 response in Myd88FL/FL Cd4-cre mice. Thus, we asked
whether this response produces memory T cells at a frequency
similar to WT mice. We immunized Myd88FL/FL Cd4-cre mice
and WT controls with 2W peptide + LPS in IFA in the presence
or absence of Treg cells and isolated the draining lymph nodes
30–60 days later. By this time almost about half of 2W:I-Ab+
CD4+ T cells of both Myd88FL/FL Cd4-cre mice and WT controls
represented CD44+ CD62L+ memory T cells, irrespective of
whether or not Treg cells were present during the immunization
(Figure 6A). There was no difference between Myd88FL/FL Cd4-
cre and WT control mice. Likewise, the lymph nodes of both
Myd88FL/FL Cd4-cre mice and WT controls harbored equal
frequencies of Ly-6C+ CXCR5 PD-1 Th1 effector memory
cells, Ly-6C CXCR5+ PD-1 central memory CD4+ T cells,
and Ly-6C CXCR5+ PD-1+ Tfh cells (Figure 6B). These results
suggest that in Myd88FL/FL Cd4-cre mice, antigen-specific
CD4+ T cells become antigen-experienced and form memory
cells at similar frequencies as WT mice, even under conditions
where Treg cells are present.
We then asked whether the CD4+ memory T cell response is
functionally impaired. We immunized Myd88FL/FL Cd4-cre mice
and WT controls with OVA + LPS in IFA in either the presence
or absence of Treg cells and reimmunized these mice 60 days
Figure 6. Memory CD4+ T Cell Response in Myd88FL/FL Cd4-cre Mice
(A and B) Frequency of 2W:I-A(b)+ memory CD4+ T cells in MyD88T-KO Myd88FL/FL Cd4-cremice and WT controls. The frequency of 2W:I-A(b)+ CD4+ T cells and
2W:I-A(b)+ memory CD4+ T cells was determined 40–60 days after immunization with 2W peptide + LPS in IFA. The mice were immunized either in the presence
( aCD25) or transient absence (+ aCD25) of Treg cells during the primary immunization. (A) Frequency of 2W:I-A(b)+ CD4+ T cells as a percentage of total CD4+
T cells (upper panels) and frequency of 2W:I-A(b)+ CD44+ CD62L+ memory CD4+ T cells as a percentage of total 2W:I-A(b)+ CD4+ T cells (lower panels). Values
represent mean ± SE. (B) Frequency of 2W:I-A(b)+ CXCR5 PD-1 effector memory CD4+ T, 2W:I-A(b)+ CXCR5+ PD-1 central memory CD4+ T cells, and 2W:I-
A(b)+ CXCR5+ PD-1+ Tfh cells as a percentage of total 2W:I-A(b)+ CD4+ T cells. (A and B) A representative experiment out of three independent experiments is
shown.
(C and D) CD4+memory T cell response after transient depletion of CD25+ Treg cells prior to both the primary and secondary immunization with OVA + LPS in IFA.
The proliferation measured by 3H-thymidine incorporation (C) and cytokine secretion measured by ELISA are shown (D). The data reflect representative results
from two independent experiments involving a total of four mice per genotype. Error bars reflect the SD. See also Figure S5.
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isolated CD4+ T cells from the draining lymph nodes 7 days later
and restimulated the cells with OVA in vitro as described before.
As expected, WT CD4+ T cells proliferated robustly after restim-
ulation and secreted IFN-g and IL-17, irrespective of whether or
not Treg cells were present during both the primary and sec-
ondary immunization. In contrast, CD4+ T cells from Myd88FL/FL
Cd4-cre mice failed to expand like WT cells and did not secrete
large amounts of cytokines. Surprisingly, this was also the case
under conditions in which Treg cells were absent during both the
primary and secondary immunization (Figures 6C and 6D; Fig-
ure S5). Therefore, although memory CD4+ T cells do not appear
to be dependent on IL-1 for their generation, they do require this
cytokine in order to become functionally competent, suggestinga dependence on IL-1 that goes beyond a requirement for IL-1 to
overcome Treg cell-mediated suppression.
IL-1 and IL-6 Induce Different Gene-Expression
Programs.
The phenotype of Myd88FL/FL Cd4-cre mice resembled that of
mice with a T cell-specific ablation of IL-6 signaling (Il6raFL/FL
Cd4-cre mice) as both IL-1 and IL-6 are essential for the gener-
ation of a Th1 cell response in the presence of Treg cells, but not
essential in the absence of Treg cells (S.A.N., D.S., and R.M.,
unpublished data). It had been previously suggested that IL-6 in-
duces the IL-1R and thus increases the sensitivity of CD4+ T cells
to IL-1 (Chung et al., 2009).We therefore askedwhether IL-1 reg-
ulates a subset of the IL-6-dependent gene-expression programImmunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc. 85
Figure 7. Gene-Expression Analysis of Myd88FL/FL Cd4-cre and Il6raFl/FL Cd4-cre IL6RaT-KO Mice Compared to WT Controls
(A) RNASeq of antigen-specific 2W:I-A(b)+ CD4+ T cells from the draining lymph nodes ofMyd88FL/FL Cd4-cre, Il6raFl/FL Cd4-cre, and WT control mice that were
isolated by flow cytometry 7 days after immunization with 2W peptide + LPS in IFA.
(B) Principal component analysis of antigen-specific T cells of Myd88FL/FL Cd4-cre, Il6raFl/FL Cd4-cre, and WT control mice.
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sion programs with little overlap. We isolated 2W:I-Ab+ CD4+
T cells from the draining lymph nodes of immunized Myd88FL/FL
Cd4-cre, Il6raFL/FL Cd4-cre, and WT mice and analyzed polyA-
containing RNAs by high-throughput sequencing (RNA-Seq).
Comparison of the gene-expression profiles of MyD88-, and
IL6Ra-deficient CD4+ T cells mice with that of WT controls
revealed that IL-1 and IL-6 modified the expression levels of
distinct sets of genes that have only a few genes in common
with each other (Figure 7A). A principal component analysis
(PCA) confirmed this further as the vectors for both Myd88FL/FL
Cd4-cre and Il6raFL/FL Cd4-cre mice were not only distinct
from that of WT controls but also different from each other (Fig-
ure 7B). We therefore conclude that IL-1 and IL-6 regulate
different processes that are both required for an optimal CD4+
T cell response.
DISCUSSION
Here, we have shown that T cell-intrinsic MyD88 activation
delivers an important signal for the induction of CD4+ T cell
responses in vivo. While T cell-specific TLR2 signaling can
augment the generation of Th17 cell responses (Reynolds
et al., 2010), we did not observe a major role for T cell-specific
TLR4 or TLR9 activation in the generation of either Th1 or Th17
cell responses, at least not under the conditions used in our86 Immunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc.experiments. We also did not observe an impact of IL-18
signaling on the generation of the CD4+ T cell response. Consis-
tent with this, we found that the expression of the IL-18 receptor
is reduced in antigen-specific CD4+ T cells after immunization.
IL-18 is usually seen as a cytokine that promotes Th1 cell
responses. However, Th1 cell responses do not universally
depend on this cytokine because Th1 cells can be generated
in absence of IL-18 signaling in certain experimental settings
(Haring and Harty, 2009; Su et al., 2005). Instead, we found
that the impairment of the CD4+ T cell response in Myd88FL/FL
Cd4-cre mice was due to the lack of IL-1 signaling. The role of
IL-1 in the differentiation of Th17 cells has been appreciated in
recent years and our results confirm the central role for this cyto-
kine in the generation of this T cell subset. Importantly, however,
we found that IL-1 also plays an important role in the induction of
Th1 cell responses.
MyD88 and, by extension, TLR activation in T cells had been
previously suggested to deliver a survival signal to CD4+
T cells, in part via the upregulation of BCLXL (Gelman et al.,
2006; Rahman et al., 2008). Likewise, IL-1 had also been impli-
cated in the provision of a survival signal to CD4+ T cells
(Ben-Sasson et al., 2009). The absence of such a signal could
have explained the phenotype that we observed in Myd88FL/FL
Cd4-cre mice. However, antigen-specific MyD88-deficient
CD4+ T cells proliferated normally and did not exhibit an
increased tendency to undergo apoptosis. Consistent with this
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similar frequency inMyd88FL/FL Cd4-cremice as in WT controls.
Thus, the provision of a survival signal per se is unlikely to be a
major function of IL-1 in this context.
Instead, we could restore the Th1 cell response inMyd88FL/FL
Cd4-cre mice in the absence of Treg cells, while the Th17 cell
response remained defective, presumably because of the
additional requirement of IL-1 for the differentiation of Th17 cells.
IL-1 signaling had been previously suggested to compromise the
suppressive capability of Treg cells (Mercer et al., 2010;
O’Sullivan et al., 2006). The normal CD4+ T cell response in
Myd88FL/FL Foxp3-cre mice suggests that this was not the
case and points toward a function for IL-1 in either the naive or
effector CD4+ T cell compartment. The reciprocal relationship
between developing Th17 cells and Treg cells can lead to an
increase in iTreg cells in the absence of the former cells. This is
the case in mice that are deficient in IL-6 signaling, at least under
some conditions (Bettelli et al., 2006; Korn et al., 2008). A similar
function has also been suggested for IL-1 (Chung et al., 2009).
Because Myd88FL/FL Cd4-cre mice fail to generate Th17 cells,
an increase of iTreg cells after immunization could have ex-
plained the impaired Th1 cell response in these animals. We
usedmultiple different approaches in order to detect an increase
in the frequency of iTreg cells in Myd88FL/FL Cd4-cre mice but
were unable to find strong evidence for this. It is therefore likely
that IL-1 acts on naive or effector CD4+ T cells in order to render
them refractory to the suppressive effects of naturally-occurring
nTreg cells.
The generation of a Th1 cell response in Myd88FL/FL Cd4-cre
mice in the absence of Treg cells allowed us to determine the
role of MyD88 signaling in memory T cells. Surprisingly,
Myd88FL/FL Cd4-cre mice generated antigen-specific CD4+
memory T cells at WT frequencies. However, CD4+ memory
T cells were impaired in their ability to differentiate into IFN-g-
secreting T cells after secondary immunization, even under con-
ditions where Treg cells were absent during both the primary and
secondary immunization. In the context of a Th1 cell response,
the IL-1 signal seems therefore to carry additional information
that goes beyond the release of naive or effector CD4+ T cells
from Treg cell-mediated suppression. One possibility could be
that during the primary immunization, CD4+ T cells fail to fully
differentiate into memory CD4+ T cells and thus are present after
the primary immunization in a functionally compromised state.
Alternatively, the requirement for IL-1 signaling during a second-
ary Th1 cell response even in the absence of Treg cells might
reflect activation requirements that are unique for memory
CD4+ T cells. Indeed, it has been suggested that the expansion
of memory CD4+ T cells is sensitive to IL-1 signaling after sec-
ondary challenge with antigen (Luqman et al., 1992). This aspect
might be an intrinsic feature of memory CD4+ T cells that is
independent of their control by Treg cells and might thus explain
the lack of a memory CD4+ T cell response in Myd88FL/FL Cd4-
cre mice even after transient depletion of Treg cells during the
secondary challenge. Further experiments will be necessary to
distinguish between these possibilities.
Our study has addressed the function of CD4+ T cell-specific
MyD88 signaling in the context of immunizations by using TLR
ligands as adjuvants. IL-1 induced under these conditions was
required for the induction of a Th1 cell response. However, it iscertainly possible that other cytokines or membrane-bound sig-
nals carry similar information and are also releasing CD4+ T cell
from Treg cell-mediated suppression, particularly as a conse-
quence of the activation of other PRR systems. In this regard,
it is interesting to note that IL-4 and IL-15 have been proposed
to operate in this manner (Ben Ahmed et al., 2009; Thornton
et al., 2004). Thus, cytokines induced by different types of infec-
tions might function in a way analogous to IL-1 by making naive
or effector T cells refractory to Treg cell-mediated suppres-
sion. Therefore, it remains to be seen to what extent IL-1 is
required to overcome Treg cell-mediated suppression upon
live infections.
IL-6 had been previously implicated in the release of CD4+
T cells from Treg cell-mediated suppression (Pasare and Medz-
hitov, 2003). The observation that Myd88FL/FL Cd4-cre and
Il6raFL/FL Cd4-cre mice share a similar overall phenotype sup-
ports the notion that that IL-1 and IL-6 both cooperate in this pro-
cess in vivo (S.A.N., D.S., and R.M., unpublished data). IL-6 has
been reported to induce the expression of the IL-1R on CD4+
T cells (Chung et al., 2009). However, several lines of evidence
point to a distinct function of these cytokines in the CD4+ T cell
response. First, the phenotype of Il6raFL/FL Cd4-cre mice tends
to be stronger than that of Myd88FL/FL Cd4-cre mice and we
would expect the opposite to be true if IL-6 wasmerely a permis-
sive signal. Moreover, we noticed subtle but important differ-
ences in the CD4+ T cell response between these strains as the
frequency of antigen-specific CD4+ T cells was reduced in
Il6raFL/FL Cd4-cre mice, but not in Myd88FL/FL Cd4-cre mice.
Finally, the comparison of the gene-expression profiles of anti-
gen-specific CD4+ T cells from Il6raFL/FL Cd4-cre mice and
Myd88FL/FL Cd4-cre mice revealed little overlap in the differen-
tially expressed genes. It therefore seems more likely that IL-1
and IL-6 integrate different aspects of the immunological chal-
lenge. This notion is particularly interesting in light of the unique
mechanism involved in IL-1 secretion, namely the requirement
for inflammasome activation (Strowig et al., 2012). Inflamma-
some activation requires both a TLR signal and a second signal
that can be triggered by microbial virulence activities (Brodsky
and Monack, 2009). Thus, IL-1 can ‘‘report’’ microbial virulence
activity to CD4+ T cells (Brodsky et al., 2010). IL-1 also signals
the presence of live infections, at least under some circum-
stances (Sander et al., 2011). The critical role of IL-1 in CD4+
T cell responses might therefore reflect its unique expression re-
quirements: while TLR activation reports on microbial origin of
antigens, IL-1 expression might indicate the nature or the status
of microbial threat (live versus dead, innocuous versus virulent).
While antigen origin can be either microbial or not, virulence is
a graded function (pathogen can be more or less virulent) as is
the viability at the level of a microbial population. Interestingly,
CD4+ T cell susceptibility to Treg cell-mediated suppression
also appears to be a graded phenomenon and can be shifted in
either direction by varying the conditions of T cell activation
(Shevach, 2009). Therefore, the amount of IL-1 production might
calibrate CD4+ T cell responses by controlling susceptibility of
CD4+ T cells to suppression by Treg cells. Notably in this regard,
the commonly used adjuvants alum and mineral oil (in Freund’s
adjuvants), might function as mimics of microbial virulence or
viability signals that normally induce inflammasome activation,
whereas microbial TLR and other PRR ligands instruct theImmunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc. 87
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notion, at least some adjuvants are known to activate inflam-
masomes (Lambrecht et al., 2009). Both types of signals must
be present in vaccine formulations for the efficient induction of
CD4+ T cell responses.
EXPERIMENTAL PROCEDURES
Generation of the Conditional Myd88 Allele
The targeting vector was based on a derivative of the pEZ-flox vector that
contained a FRT-flanked neoR cassette and a diphtheria toxin gene for
negative selection (Schenten et al., 2002). PCR fragments containing the
appropriate restriction sites were amplified from a C57BL/6-derived BAC
encoding MyD88 and inserted into the targeting vector. The culture and trans-
fections of C57BL/6-derived Bruce4 embryonic stem cells (ESCs) has been
published previously. Targeted ESC clones were identified by Southern
hybridization of EcoRI-digested genomic DNA with probe A, which was PCR
amplified from a MyD88-encoding BAC using primers 50-ACTAAACCCGGG
GATGGGGGTG and 50CTTCCCTTAAGTCTCCTGCCAGCC. Cointegration of
the second loxP site was confirmed by Southern hybridization of HinDIII-
digested ES cell DNA with probe C. That probe was amplified with primers
50-GACAAACGCCGGAACTTTTCGATGG and 50-AGAAGTACAAAGTACAAA
CACGAGCCC. The neoR cassette was deleted in vitro by transfection of a
FLIP recombinase encoding plasmid and confirmed by Southern blotting of
EcoRI-digested ESC DNA with probe A. A correctly targeted ESC clone was
injected C57BL/6 albino-derived blastocysts, which were implanted into
pseudopregnant C57BL/6 foster mice in order to generate chimeric mice
and achieve germline transmission. Mice carrying the floxed Myd88 allele
(Myd88FL mice) were viable and born at Mendelian ratios.
Mice
In order to ablate MyD88 function specifically in T cells, Myd88FL mice were
intercrossed with mice carrying a Cd4-cre allele (Lee et al., 2001). For some
experiments, Cd4-cre mice were used as controls in order to monitor for
negative effects of Cre activity. FoxP3+ Treg cell-specific deletion was
achieved by intercrossing Myd88FL mice with Foxp3-cre mice (Rubtsov
et al., 2008). Il1r/ mice, Il18r/ mice, and Tcrb/ and Tcrd/ compound
mutant mice were purchased from the Jackson Laboratory (Glaccum et al.,
1997; Hoshino et al., 1999). Tlr9/ mice and Tlr2/ and Tlr4/ compound
mutant mice were maintained at the Yale School of Medicine. All mice were
kept on a C57BL/6 genetic background. The mice were housed in the Yale
Animal Resources Center (YARC) and the experiments were done with
approval by the Yale University Institutional Animal Care and Use Committee
(IACUC).
Immunizations
The mice were immunized in both feet with either 100 mg/mouse OVA (Sigma)
or 100 mg/mouse 2W1S peptide (EAWGALANWAVDSA, Genscript) plus
10 mg/mouse LPS (Sigma) emulsified in incomplete Freund’s adjuvant (Sigma).
For some experiments, LPS was replaced with either 20 mg/mouse CpG DNA
1826 (Keck Biotechnology Resource Laboratory, Yale Medical School),
50 mg/mouse polyI:C (Invivogen), 20 mg/mouse Peptidoglycan (Invivogen), or
150 mg/mouse heat-inactivated M. tuberculosis (Sigma). The effects of
contaminating endotoxin in the OVA preparations were controlled by using
endotoxin-free OVA (Hyglos/Biovendor) in key experiments. CD4+ memory
responses were induced similarly with the exception that one foot was used
for the primary immunization, while the other foot was used for the secondary
immunization 30–60 days later.
Antibodies and Other Reagents
All standard antibodies for flow cytometry were purchased from either BD
Biosciences or Ebiosciences. FITC-PNA was purchased from Biovector,
and the a-activated caspase-3 antibody was obtained from R&D Systems.
PE-conjugated 2W:I-Ab tetramers were a gift from Marc Jenkins (University
of Minnesota). Bromodeoxyuridine (BrdU) incorporation was measured
with the BrdU staining kit from BD Bioscences. The a-CD25 antibody
PC61 was purified from hybridoma cells adapted to serum-free medium88 Immunity 40, 78–90, January 16, 2014 ª2014 Elsevier Inc.and grown in Cellline 2-compartment bioreactors (BD Biosciences).
MyD88 protein was detected by immunoblotting with a goat a-MyD88
antibody (R&D Systems).
T Cell Assay
CD4+ T cells were isolated from the popliteal and inguinal lymph nodes 7 days
after immunization by magnetic cell sorting with aCD4 beads (Miltenyi
Biotech). The cells were seeded in round-bottom 96-well plates at a con-
centration of 100,000 cells per well in the presence of 300,000 irradiated
splenocytes in the presence of serial dilutions of OVA, starting at 900 mg/ml.
Proliferation was measured on day 4 following the addition of 3H-thymidine
for the last 24 hr and the secretion of IFN-g and IL-17 was measured by ELISA
or intracellular flow cytometry.
Treg Cell Depletion
Treg cells were depleted in vivo with 150 mg/mouse of an aCD25 antibody
(clone PC61) by intravenous injection 3 days prior to immunization. Depletion
of Treg cells was confirmed on the day of immunization by flow cytometry upon
staining of CD4+ T cells from the blood with an aCD25 antibody (clone 7D4).
Bone Marrow Chimeras
Bone marrow from Tcrb/ and Tcrd/ compound mutant mice was mixed in
a ratio of 3:1 with bone marrow isolated from C57BL/6 WT mice, Il1r/ mice,
Il18r/ mice, Tlr9/ mice, or Tlr2/ and Tlr4/ compound mutant mice.
We injected 10 3 106 total cells per mouse into Rag2/ mice that had been
lethally irradiated with 900 rad 1 day prior to the bone marrow transfer. The
reconstitution of the hematopoetic system was confirmed after 6 weeks by
flow cytometry.
RNA-Seq
Antigen-specific CD4+ T cells were isolated by flow cytometry from a total of
15–20 immunized mice per genotype. RNA was isolated from approximately
100,000 cells per genotype with the RNeasy isolation kit (QIAGEN) and
processed and sequenced by the Yale Center for Genome Analysis (YCGA).
Statistical Analysis
Data were analyzed with a Student’s t test with Prism4 (Graphpad Software). In
case with abnormal distribution, the data were also analyzed with a Mann-
Whitney test using the same software. Unless not mentioned specifically,
data are shown as mean ± SD. p values: *, p % 0.05; **, p % 0.005; ***, p %
0.0005; n.s., not significant. PCA analysis of gene-expression data was
performed with R (2.15.3).
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